【CPHI Shanghai】Haibu Pharmaceutical is eagerly waiting at booth E6E25!

Beijing Haibu Pharmaceutical Technology Co., Ltd. (referred to as 'Haibu Pharmaceutical') was established in 2005 and is a high-tech enterprise with 'chemical drug R&D' as its core capability. It has a research and development center in Beijing, a pilot validation center for raw materials and formulations, and a GMP industrial production base, mainly engaged in CRO services for raw materials and formulations, MAH joint licensing, raw material-related applications, and commercial supply of pharmaceutical intermediates.It has rich experience in the R&D transfer production, registration application, etc., of various dosage forms such as chemical raw materials, oral solids, liquid preparations, sterile injections, and external preparations. The R&D products cover multiple therapeutic areas including anti-tumor, anti-depression, anti-epilepsy, anti-anxiety, cardiovascular and cerebrovascular diseases, digestive system diseases, respiratory system diseases.

Haibu Pharmaceutical has been awarded the title of 'Top 20 Chinese Pharmaceutical R&D Companies' for many years and recognized as a 'Specialized & Innovative Enterprise' by Beijing Municipality, a 'National High-tech Enterprise', a 'Beijing Science and Technology Research Development Institution', and a 'Beijing Yizhuang Enterprise Innovation Center', among others.